Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.

Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):84-9.

2.

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ.

J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.

PMID:
10203281
3.

Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.

Holmes MD, Pollak MN, Willett WC, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):852-61.

4.

Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.

Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH.

Cancer Causes Control. 2004 Oct;15(8):787-96.

PMID:
15456992
5.

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.

Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.

Breast Cancer Res Treat. 2004 Nov;88(1):63-73.

PMID:
15538047
6.

Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1107-10.

7.

Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.

Jacobs ET, Martínez ME, Alberts DS, Ashbeck EL, Gapstur SM, Lance P, Thompson PA.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):300-5. doi: 10.1158/1055-9965.EPI-07-0764. Epub 2008 Feb 4.

8.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

9.

Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men.

Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S.

Am J Epidemiol. 2002 Aug 15;156(4):344-8.

PMID:
12181104
10.

Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.

Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.

11.

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.

Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D.

Urology. 2004 Aug;64(2):317-22.

PMID:
15302487
12.

Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

Axelsson J, Qureshi AR, Divino-Filho JC, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.

Eur J Clin Nutr. 2006 Jun;60(6):718-26. Epub 2006 Jan 4.

PMID:
16391585
13.
14.
15.

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):748-52.

16.
17.

Cross-sectional associations of diet and insulin-like growth factor levels in 7- to 8-year-old children.

Rogers IS, Gunnell D, Emmett PM, Glynn LR, Dunger DB, Holly JM.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):204-12.

18.

Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.

Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8.

19.
20.

Disturbance of the growth hormone-insulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors.

Okamoto I, Munakata M, Miyazaki M, Satoh T, Takahata T, Takamatsu Y, Muto O, Koike K, Ishitani K, Mukaiyama T, Sakata Y, Nakagawa K, Tamura K.

Jpn J Clin Oncol. 2010 Mar;40(3):222-6. doi: 10.1093/jjco/hyp155. Epub 2009 Nov 25.

PMID:
19942582

Supplemental Content

Support Center